News

2017 Apr 28

WorldQuant Initiative for Quantitative Prediction Established at Weill Cornell Medicine

NEW YORK (April 28, 2017) – Weill Cornell Medicine today announced a gift made by WorldQuant, LLC (“WorldQuant”) and Igor Tulchinsky that will further realize the promise of precision medicine. The $5 million gift... Read more

2017 Apr 28

Hitting Her Stride

Profile of Lisa Roth, M.D., as an oncologist, cancer survivor and distance runner Read more

Igor Tulchinsky, Dr. Christopher Mason and Dr. Olivier Elemento

2017 Apr 28

WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine

A $5 million gift will establish a new initiative to use predictive tools to enhance Weill Cornell Medicine’s precision medicine efforts. Read more

Drs. Jeffrey Greenfield and Prajwal Rajappa

2017 Apr 28

Immune cells play crucial role in brain cancer development

Brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies, according to studies led by Jeffrey Greenfield, M.D., Ph.D. Read more

2017 Apr 26

Five Weill Cornell medical students win prestigious Howard Hughes Fellowships

Several cancer projects will get a boost thanks to prestigious research fellowships from the Howard Hughes Medical Institute. Read more

Lorraine Gudas and John Blenis at the NYC March for Science

2017 Apr 21

This professor will march to remind the world why government should support scientific exploration

Harold Varmus, M.D., explains "the profound need to reassert public support for rational thought." Read more

Dr. Adrienne Phillips. Photo credit: John Abbott

2017 Apr 20

We Are Weill Cornell Medicine: Dr. Adrienne Phillips

Profile of Adrienne Phillips, M.D., as part of the #WeAreWCM campaign. Read more

2017 Apr 18

Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy

John Leonard, M.D., discusses the optimal follicular lymphoma treatment. Read more

2017 Apr 17

New study challenges diagnostic approach for common urological condition

Combining kidney ultrasound with a visual examination of the bladder and urethra appears to be the most cost-effective way to screen for cancers of the genitourinary tract in people with microscopic amounts of blood in their urine, according to Weill Cornell urologists Read more

2017 Apr 14

Expanded drug combinations produce best myeloma induction

Ruben Niesvizky, M.D., discusses the optimal induction therapy for patients with multiple myeloma. Read more

2017 Apr 11

The federal panel that opposed prostate cancer screening just changed its mind

Jim Hu, M.D., comments on new PSA screening guidelines issued by the U.S. Preventive Services Task Force Read more

2017 Apr 07

Giving terminally ill patients the 'Right-to-Try'

Manish Shah, M.D., weighs in on proposed 'right-to-try" legislation that would give terminally ill patients access to experimental drugs. Read more

2017 Apr 06

We Are Weill Cornell Medicine: Dr. Praveen Raju

Praveen Raju, M.D., is a featured faculty member in the #WeAreWCM campaign. Read more

2017 Apr 05

In 2030, the top cancer in HIV patients may be a surprise

Ethel Cesarman, M.D., Ph.D., comments on a study about cancers linked to AIDS and suppressed immunity. Read more

2017 Apr 05

Indications of Early-Onset CRC

Manish A. Shah, M.D., discusses his research into indications of early-onset colorectal cancer. Read more

Bladder cancer survivor Irene Price and Dr. David Nanus

2017 Apr 05

Evolving therapeutic strategies in renal cell carcinoma

David Nanus, M.D., discusses evolving therapeutic strategies in the neoadjuvant and adjuvant setting for patients with RCC at the 2017 Interdisciplinary Prostate Cancer Congress. Read more

Manish Shah, M.D., gastrointestinal oncology expert at the Meyer Cancer Center of Weill Cornell Medicine

2017 Apr 05

Long-term aspirin may cut risk for cancer death

Manish Shah, M.D., comments on a study about the association of long-term aspirin use and cancer death. Read more

A group of people together posing for a photo

2017 Apr 03

Investigators Named to Stand Up 2 Cancer’s Colorectal Dream Team

Weill Cornell Medicine and NewYork-Presbyterian have been named to the nonprofit Stand Up 2 Cancer’s Colorectal Dream Team to drive new advances in colorectal cancer research and treatment. The interdisciplinary team, funded... Read more

Lew Cantley and Katie Couric at Stand Up to Cancer/AACR announcement event

2017 Apr 03

Weill Cornell Medicine joins colorectal cancer 'Dream Team'

A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers. Read more

2017 Apr 02

Bringing bladder cancer into focus

Bishoy Faltas, M.D., and LaMont Barlow, M.D., are exploring FAK inhibition as a potential targeted therapy for urothelial cancer. Read more

News

WorldQuant Initiative for Quantitative Prediction Established at Weill Cornell Medicine

Hitting Her Stride

WorldQuant Initiative for Quantitative Prediction established at Weill Cornell Medicine

Immune cells play crucial role in brain cancer development

Five Weill Cornell medical students win prestigious Howard Hughes Fellowships

This professor will march to remind the world why government should support scientific exploration

We Are Weill Cornell Medicine: Dr. Adrienne Phillips

Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy

New study challenges diagnostic approach for common urological condition

Expanded drug combinations produce best myeloma induction

The federal panel that opposed prostate cancer screening just changed its mind

Giving terminally ill patients the 'Right-to-Try'

We Are Weill Cornell Medicine: Dr. Praveen Raju

In 2030, the top cancer in HIV patients may be a surprise

Indications of Early-Onset CRC

Evolving therapeutic strategies in renal cell carcinoma

Long-term aspirin may cut risk for cancer death

Investigators Named to Stand Up 2 Cancer’s Colorectal Dream Team

Weill Cornell Medicine joins colorectal cancer 'Dream Team'

Bringing bladder cancer into focus

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters